283 related articles for article (PubMed ID: 26416675)
1. Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke.
Weissman I
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140364. PubMed ID: 26416675
[TBL] [Abstract][Full Text] [Related]
2. Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia.
Aroldi A; Mauri M; Ramazzotti D; Villa M; Malighetti F; Crippa V; Cocito F; Borella C; Bossi E; Steidl C; Scollo C; Voena C; Chiarle R; Mologni L; Piazza R; Gambacorti-Passerini C
J Cell Mol Med; 2023 Oct; 27(20):3053-3064. PubMed ID: 37654003
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells: a review.
Spillane JB; Henderson MA
ANZ J Surg; 2007 Jun; 77(6):464-8. PubMed ID: 17501888
[TBL] [Abstract][Full Text] [Related]
4. The overall potential of CD47 in cancer immunotherapy: with a focus on gastrointestinal tumors.
Tzatzarakis E; Hissa B; Reissfelder C; Schölch S
Expert Rev Anticancer Ther; 2019 Nov; 19(11):993-999. PubMed ID: 31686549
[No Abstract] [Full Text] [Related]
5. Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.
Kaur S; Roberts DD
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):184-194. PubMed ID: 27163531
[TBL] [Abstract][Full Text] [Related]
6. SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.
Tahk S; Vick B; Hiller B; Schmitt S; Marcinek A; Perini ED; Leutbecher A; Augsberger C; Reischer A; Tast B; Humpe A; Jeremias I; Subklewe M; Fenn NC; Hopfner KP
J Hematol Oncol; 2021 Sep; 14(1):155. PubMed ID: 34579739
[TBL] [Abstract][Full Text] [Related]
7. A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer.
Betancur PA; Abraham BJ; Yiu YY; Willingham SB; Khameneh F; Zarnegar M; Kuo AH; McKenna K; Kojima Y; Leeper NJ; Ho P; Gip P; Swigut T; Sherwood RI; Clarke MF; Somlo G; Young RA; Weissman IL
Nat Commun; 2017 Apr; 8():14802. PubMed ID: 28378740
[TBL] [Abstract][Full Text] [Related]
8. Normal and neoplastic stem cells.
Weissman IL
Novartis Found Symp; 2005; 265():35-50; discussion 50-4, 92-7. PubMed ID: 16050249
[TBL] [Abstract][Full Text] [Related]
9. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
[TBL] [Abstract][Full Text] [Related]
10. Origin of cancer stem cells: the role of self-renewal and differentiation.
Wu XZ
Ann Surg Oncol; 2008 Feb; 15(2):407-14. PubMed ID: 18043974
[TBL] [Abstract][Full Text] [Related]
11. Role of CD47 in Hematological Malignancies.
Eladl E; Tremblay-LeMay R; Rastgoo N; Musani R; Chen W; Liu A; Chang H
J Hematol Oncol; 2020 Jul; 13(1):96. PubMed ID: 32677994
[TBL] [Abstract][Full Text] [Related]
12. Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells.
Majeti R; Jamieson C; Pang WW; Jaiswal S; Leeper NJ; Wernig G; Weissman IL
Annu Rev Med; 2022 Jan; 73():307-320. PubMed ID: 35084991
[TBL] [Abstract][Full Text] [Related]
13. Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47.
Tan W; Tang H; Jiang X; Ye F; Huang L; Shi D; Li L; Huang X; Li L; Xie X; Xie X
J Cell Mol Med; 2019 Sep; 23(9):5994-6004. PubMed ID: 31273952
[TBL] [Abstract][Full Text] [Related]
14. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
15. How One Thing Led to Another.
Weissman I
Annu Rev Immunol; 2016 May; 34():1-30. PubMed ID: 27168238
[TBL] [Abstract][Full Text] [Related]
16. HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.
Zhang H; Lu H; Xiang L; Bullen JW; Zhang C; Samanta D; Gilkes DM; He J; Semenza GL
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):E6215-23. PubMed ID: 26512116
[TBL] [Abstract][Full Text] [Related]
17. Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny.
Ashkenazi R; Gentry SN; Jackson TL
Neoplasia; 2008 Nov; 10(11):1170-82. PubMed ID: 18953426
[TBL] [Abstract][Full Text] [Related]
18. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
[TBL] [Abstract][Full Text] [Related]
19. Role of epithelial stem/progenitor cells in mammary cancer.
Bruno RD; Smith GH
Gene Expr; 2011; 15(3):133-40. PubMed ID: 22268295
[TBL] [Abstract][Full Text] [Related]
20. Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on.
Mohanty S; Aghighi M; Yerneni K; Theruvath JL; Daldrup-Link HE
Mol Oncol; 2019 Oct; 13(10):2049-2061. PubMed ID: 31376208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
